Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA) -- Ignore unavailable to you. Want to Upgrade?

To: David C who wrote (1266)	12/29/1999 1:35:00 AM
From: billkirn	Respond to of 1870

Dave: My take on the future price of Genta would be limited somewhat because it is a one drug, potentially great drug, company with no long term research potential. No pipe line for future products. So if their drug is as successful as I think it will be, the stock may reach 35 to 40 max. over the next 3 years. Things may change if they can generate revenue, elevate their stock price, maybe buy some promising biotech companies like ISIS in a few years. Good Luck Bill

To: David C who wrote (1266)	12/29/1999 8:17:00 AM
From: Curtis Frazier	Respond to of 1870

Personally, I think a cancer cure should send it to $100 easily. Think about it, money would be no object when it comes to curing cancer because there is no cure. GNTA will become a cash cow then.

To: David C who wrote (1266)	12/29/1999 10:46:00 AM
From: Larry Dreher	Read Replies (1) \| Respond to of 1870

>>What is Murphy saying about Genta these days? I thought you might know since you have been in this one so long. << Pardon me for jumping in. I've been in Genta for several years too. I did manage to average down after the reverse split though. Murphy recommended a sell a couple of issues back on Genta. I don't have my old issues around but I think I remember him having a 5-6 dollar target on the stock. Murphy's timing stinks. I use him to bring companies to my attention but my general rule of thumb is follow his picks till they bust and then buy in then. Same deal with AMLN, he recommended the stock around 6. It busted and went under 50 cents. It has now recovered to the $7+ range. I've read the other opinions on Genta here but I can;t help but think this would be a $100 stock if the trials on their lead compound are successful. Good luck to all of us. Larry